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The use of direct susceptibility testing from specimens has led to the fortuitous observa-
tion that penicillin-susceptible strains have larger inhibition zones for mecillinam than do
b-lactamase producers. The current study was, therefore, undertaken to test 179 Staphy-
lococcus aureus isolates for mecillinam susceptibility by Rosco Neo-Sensitabs and to
compare the results with commonly used tests for b-lactamase production, i.e. size
and character of penicillin inhibition zones, chromogenic cephalosporin (nitroceﬁn) tests
and clover leaf assays. Agreement between methods was reached for 175 of 179 strains
when disregarding the results of the nitroceﬁn tests, 88 isolates being found susceptible
and 87 being found to be b-lactamase producers. All 88 susceptible isolates had
mecillinam zones of >22mm, with the great majority being >25mm; double zones
did, however, occur. The 87 b-lactamase producers had zones <14mm or no zones. Four
isolates presenting problems in had mecillinam zones of 20mm and were without
tapering growth at the penicillin inhibition zone edge. In conclusion, the size of the
mecillinam inhibition zone is found to be a useful supplementary test in the clinically
important distinction between b-lactamase-producing and non-producing isolates of S.
aureus.
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The present study was undertaken following per-
sonal observations on the part of both investiga-
tors, of b-lactamase-producing S. aureus strains
sometimes beingmisread as penicillin-susceptible.
As reporting of penicillin susceptibility leads
to treatment of S. aureus infections with penicil-
lin, due to this agent’s greater activity against
penicillin-sensitive staphylococci compared to b-
lactamase-stable penicillins, faulty reporting of
penicillin susceptibility can have dire conse-
quences. It is, therefore, of great importance to be
able to make correct distinctions between b-lacta-
mase-producing and non-producing strains in the
clinical microbiology laboratory.
The routine use of direct susceptibility testing of
specimens in Danish laboratories has led to the
fortuitous observation that penicillin-susceptible
S. aureus isolates have larger inhibition zones
for mecillinam than do b-lactamase-producing
isolates. The aim of the present study was, to test
a collection of S. aureus strains for mecillinam
susceptibility and to compare the results with
those of other commonly used tests for detection
of b-lactamase production.
One hundred and forty-four clinical S. aureus
isolates consecutively collected from 144 patients
were studied. Presumptively, penicillin-suscepti-
ble and -resistant isolates were collected indepen-
dently of each other in order to obtain a sufﬁcient
number of penicillin-susceptible strains. Also
included was a recent clinical isolate that pre-
sented problems in interpretation. Results were
contradictory in various tests for b-lactamase pro-
duction (no. 37) that had prompted the study, 19
strains from the Czechoslovak Collection of Micro-
organisms (including S. aureus ATCC 12600,
ATCC 3538P, ATCC 13566, ATCC 19095, NCTC
4163, NCTC 4136), S. aureus ATCC 29213 (the
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quality control strain for the CeﬁnaseTM and the
Ceﬁnase PlusTM tests), and 14 clinical strains from
the Staphylococcal Reference Laboratory, Statens
Serum Institut, Copenhagen, Denmark. Strains
were stored at 80 8C until ready for use. All
179 strains were examined in a blinded fashion
without knowledge of results from previously
performed tests.
Susceptibility testing was performed according
to the agar diffusion method using NeoSensitabs
(Rosco, Taastrup, Denmark) with Penicillin Low
(V-penicillin, 5 mg) and mecillinam (33 mg) on Dan-
ish blood agar ([1], Statens Serum Institut) with
semiconﬂuent growth [2]. This method has been
found to give fair to good agreement with MIC
values for mecillinam (agar dilution method on
Mueller–Hinton), for Gram-positive and Gram-
negative bacteria [3] and to minimum inhibitory
concentration (MIC) values for mecillinam (E test,
AB Biodisk, Solna, Sweden) for Escherichia coli [4].
These tablets have a diameter of 9mm. Incubation
was at 35 8C overnight. Inhibition zones were
measured in millimeters. A note was made as to
whether bacterial growth tapered out (‘ghost
zones’ [5]) or was clear-cut at the inhibition zone
edge. A zone of 28mm is the breakpoint between
penicillin-susceptible and b-lactamase-producing
strains [2]. No recommendations exist for mecilli-
nam in this regard.
Paper disks containing the chromogenic cepha-
losporins nitroceﬁn (CeﬁnaseTM, Becton Dickin-
son, Glostrup, Denmark) and ceﬁsone (Ceﬁnase
PlusTM, BectonDickinson) [6] were used according
to the manufacturer’s instructions, to test for b-
lactamase production. Disks were examined for
the appearance of a pink–red colored dot for up to
60min with S. aureus grown on a plate.
The clover leaf assay used was an in-house
modiﬁcation of the test described by Østravik
and Ødegaard [7]: S. aureus ATCC 25923 was used
as the indicator strain. Care was taken to produce a
dense but not conﬂuent growth on 5% horse blood
agar plates ([1], Statens Serum Institut) with the
indicator strain. The test strainwas then streaked as
a cross on the blood agar plate, starting each of the
four arms of the cross at the periphery. A Penicillin
Low tablet was placed in the center of the cross
and the plates were incubated overnight at 35 8C.
The test was read as positive for b-lactamase
production if S. aureus ATCC 25923 grew along
the streaks of the test strain toward the penicillin
tablet, resulting in a clover leaf conﬁguration. The
test was read as negative if the inhibition zone was
circular.
No singlemethodwas regarded as the deﬁnitive
reference method for detection of b-lactamase in
this study. Each strain was tested twice in agar
diffusion tests for penicillin and mecillinam, as
reading of inhibition zones for these agents is
known to be subject to some uncertainty. Discre-
pancies between the results of different methods
resulted in retesting of the involved strains at least
once, in order to ensure against mistakes such as
interchange of strains, errors of transcription, etc.
Determinations of MICs for G-penicillin with the
E test were carried out according to the manufac-
turer’s recommendations [8] in an attempt to
resolve the discrepancies.
Lack of agreement was found between the
results of the nitroceﬁn and ceﬁsone b-lactamase
tests for 12 strains, which were all nitroceﬁn nega-
tive and ceﬁsone positive. As the results of the agar
diffusion test and the clover leaf assay clearly in-
dicated b-lactamase production for these 12 strains,
only the results of the ceﬁsone test were subse-
quently taken into account. The nitroceﬁn test’s
lack of sensitivity for b-lactamases of S. aureus is in
agreement with the ﬁnding of others [6,9].
Considering the following parameters: inhibi-
tion zones for penicillin with clear-cut or tapering
edges of growth (‘ghost zones’), results of ceﬁsone
tests and clover leaf assays, complete agreement
amongmethodswas reached for 175 of 179 isolates
regarding b-lactamase production. Thus, four iso-
lates were found to be problematic, and are dis-
cussed below. Using these 175 isolates, comprising
88 penicillin-susceptible and 87 b-lactamase-pro-
ducing isolates, as the basis, the use of mecillinam
inhibition zones as a supporting test for penicillin
susceptibility could be evaluated. A total of 88
penicillin-susceptible isolates, including 10 with
penicillin zones of 28–30mm (on or very close to
the breakpoint of 28mm), were found to have
mecillinam zones of>22mm,with the greatmajor-
ity showing zones of >25mm. Three penicillin-
susceptible isolates, however, produced double
zones for mecillinam and retesting conﬁrmed
these results for two of the isolates. All 87 of the
b-lactamase-producing isolates lacked zones for
mecillinam, except for three isolates with small
zones of 10–13mm.
The results for the four isolates that presented
problems in interpretation which were all clinical,
are shown in Table 1. Three of the four isolates
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(nos. 37, 105 and 146) were judged to be b-lacta-
mase producing on the basis of an overall evalua-
tion, with mecillinam zones of 20mm, lack of
tapering growth and MICs for penicillin of
>0.1mg/L [2]; ceﬁsone tests were, however, nega-
tive upon repeated testings. The fourth isolate
(no. 136) was not assessable due to contradictory
results: size of penicillin zone and lack of ‘ghost
zone’ indicating b-lactamase production, but
the remaining tests being indicative of penicillin
sensitivity.
As 10 of 88 penicillin-susceptible isolates had
penicillin zones close to the breakpoint of 28mm
as stated above, a mecillinam zone of >22mm for
the b-lactamase non-producers actually discrimi-
nates better than the size of penicillin zones.
Thus, the presence of mecillinam zones of
>22mm is found to be a useful supplementary
test for the detection of penicillin-susceptible S.
aureus when reading directly performed suscept-
ibility tests using NeoSensitabs on Danish blood
agar. Mecillinam zone diameter interpretive
standards for this use can undoubtedly also be
worked out for other susceptibility testing sys-
tems. In a few cases, equivocal readings will,
however, necessitate secondary susceptibility tests
as described above.
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Table 1 Results of tests used for detection of b-lactamase in four problem isolates
Isolate no.
Penicillin V
zone (mm)
Tapering
growth Cefisone
Clover
leaf
Mecillinam
zone (mm)
Penicillin G
MIC (mg/L)
37 26–28 – – þ 19–20 0.125
105 25–27 – – (þ) 17–19 0.125
136 24–26 – – – 17–20 0.064
146 21–23 – – þ 0–13 0.125
– Negative results, þ positive results, (þ) weakly positive results.
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